There are now large-scale data on which common genetic variants confer risk for attention deficit hyperactivity disorder (ADHD). Here, we use mediation analyses to explore how cognitive and neural features might explain the association between common variant (polygenic) risk for ADHD and its core symptoms. In total, 544 participants participated (mean 21 years, 212 (39%) with ADHD), most with cognitive assessments, neuroanatomic imaging, and imaging of white matter tract microstructure. We found that polygenic risk for ADHD was associated with symptoms of hyperactivity-impulsivity but not inattention. This association was mediated across multiple PRS thresholds by white matter microstructure, specifically by axial diffusivity of the right corona radiata, (maximum indirect effect β = −0.034 (CI: −0.065 to −0.01), by thickness of the left dorsomedial prefrontal (β = −0.029; CI: −0.061 to −0.0047) and area of the right lateral temporal cortex (β = 0.024; CI: 0.0034-0.054). In addition, modest serial mediation was found, mapping a pathway from polygenic risk, to white matter microstructure of the anterior corona radiata, then cognition (working memory, focused attention), and finally to hyperactivity-impulsivity (working memory β = −0.014 (CI: −0.038 to −0.0026); focused attention β = −0.011 (CI: −0.033 to −0.0017). These mediation pathways were diagnostically specific and were not found for polygenic risk for ASD or schizophrenia. In conclusion, using a deeply phenotyped cohort, we delineate a pathway from polygenic risk for ADHD to hyperactive-impulsive symptoms through white matter microstructure, cortical anatomy, and cognition.
Introduction
A landmark in the genomics of attention deficit hyperactivity disorder (ADHD) was recently attained with the release of the Psychiatric Genomics Consortium genomewide association study (GWAS) of 20,183 individuals with ADHD and 35,191 controls [1] . This provides large-scale data on how common genetic variations are associated with the disorder. This advance also prompts the question of how common variants act to create the cardinal symptoms of the disorder, namely hyperactivity-impulsivity and inattention. The symptoms of ADHD are complex behavioral traits that likely reflect the effect of thousands of variants en masse, each conferring small amounts of risk, not just those surpassing a genome-wide level of significance. Using GWAS data, an index of an individual's genomic risk, often called the polygenic risk score (PRS) can be calculated as the sum of ADHD-associated alleles across the genome, weighted by their effect size [2, 3] . This PRS can be used as a starting point to examine the mechanisms that might link common genetic variant risk with symptoms.
Here, we ask which neural and cognitive features might explain the association between polygenic risk and ADHD symptoms by using mediation analyses. We first consider the microstructural properties of the white matter tracts. These tracts constitute the structural connections within the neural systems that support ADHD-related cognitive processes. ADHD is also increasingly conceptualized as the result of disrupted development of structural connectivitya "developmental dysconnectome" [4, 5] . In support of this concept, anomalies in white matter microstructure have been associated with ADHD symptom severity in children and adults [6, 7] . Meta-analyses point most robustly to anomalies within the corona radiata, corpus callosum, and cerebellum, and a study of multiplex ADHD families found several of these tracts to be highly heritable [6, 8, 9] . We also examine cortical anatomy given repeated demonstrations of altered cortical structure in the disorder [10] [11] [12] . Cortical dimensions are also highly heritable and it is likely, though not yet established, that a genetic correlation will exist with ADHD [13, 14] .
We integrate cognition by asking if there is a causal chain that links polygenic risk with neural features, which in turn are linked to cognition and finally to symptoms. We selected candidate cognitive mediators based on two criteria: association with ADHD, and significant heritability. Several domains meet these criteria: working memory, processing speed, attentional measures, and general intelligence have all been implicated in the pathogenesis of the disorder [15] [16] [17] [18] . All these cognitive skills also are significantly heritable and some show genetic overlap with the disorder [19] [20] [21] . Recently, measures of working memory and arousal were found to mediate the association between polygenic risk for ADHD and the disorder [22] . Here, we seek to replicate this initial finding and additionally consider if there are pathways from polygenic risk to symptoms that will incorporate both neural features-white matter microstructure or cerebral anatomy-and cognition.
In addition, we determine whether polygenic risk for autistic spectrum disorders (ASD) is associated with symptoms of ADHD and if this association is explained by similar neurocognitive mechanisms. We consider ASD as it overlaps substantially with ADHD, at phenotypic [23] [24] [25] , cognitive [17, 26, 27] , and genetic levels [28] [29] [30] . We also consider PRS for schizophrenia, which while a neurodevelopmental disorder, shows less overlap with ADHD than ASD at clinical, cognitive, and genomic levels [31, 32] . Thus, compared with ASD, we would predict little overlap between polygenic risks for ADHD and schizophrenia in association with cognitive and clinical features.
In summary, we delineate associations between the PRS for ADHD and symptoms of the disorder, asking if they are mediated through neural and cognitive factors. We draw contrasts with polygenic risks for other disorders, predicting some overlap with the polygenic risk for ASD, but not for schizophrenia. We advance the field by examining these multiple facets-polygenic risk, the brain, cognition, and symptoms-all within the same deeply phenotyped cohort, using mediation analyses to identify neural and cognitive variables that lie in the causal sequence between polygenic risk and symptoms.
Methods
In all, 544 individuals participated. Our primary analyses were conducted on the largest subpopulation (489 white, non-Hispanic individuals) to avoid issues of population stratification. However, we also report on analyses that incorporated the second largest subpopulation of 55 individuals with African American ancestry-see Supplement A1 for the determination population substructure. The general inclusion criteria were (1) age above 3 years (2) Intelligence Quotient of 70 or greater [33] [34] [35] [36] . General exclusion criteria were (1) neurological disorders known to affect movement, except tic disorders; (2) psychiatric disorders other than ADHD, oppositional defiant disorder, conduct disorder, post-traumatic stress disorder, autistic spectrum disorder, mood or anxiety disorders. Symptoms of inattention and hyperactivity disorder were ascertained using clinician-administered structured interviews-Supplement A2. The participants originated from 330 families. Overall, 190 (39%) within the white, non-Hispanic subpopulation met criteria for ADHD. Details of medications and comorbid disorders are given in Supplemental  Tables B1-B3 . The procedures were approved by the Institutional Review Board of the National Human Genome Research Institute. All adult participants gave written consent. Parents or guardians of children gave written consent and children gave assent.
Neuroimaging
High-resolution T1-weighted anatomic sequences were collected on a 3-T GE Signa scanner. Parameters and quality control measures are detailed in the Supplement A3, and included visual inspection by at least two trained, reliable raters of the "raw" data and FreeSurfer cortical reconstructions (thickness and surface area). Following quality control, 325 of 472 scans were retained. Diffusion tensor imaging (DTI) data were acquired using a single-shot, dual-spin echo, echo-planar imaging sequence (see Supplement A3). Qualitycontrol measures included the reacquisition of corrupted data in real time, visual inspection, exclusion of participants with more than two corrupted volumes, outlying fractional anisotropy, axial, radial diffusivity metrics. Overall, 383 of the original 448 DTI data sets were retained. Although there were no significant correlations between residual motion, symptoms, and diffusion parameters we nonetheless regressed out residual motion along with age and sex from diffusion measures and conducted analyses on the residuals. Tract-based spatial statistics were then applied to create a group mean image, the "skeleton", which represents the center of all tracts in the study cohort. The skeleton was thresholded at a fractional anisotropy (FA) value of > 0.2 and analyses were conducted on voxels within this skeleton [37] .
Cognitive assessment
Working memory spans were assessed through the number of correctly recalled digits/tapping patterns in original and reverse order [38] . Processing speed was assessed using the visual matching task, which requires participants to circle two identical numbers under time pressure; and the decision speed task which requires participants to match two images under time pressure (from the Woodcock Johnson III Test of Cognitive Abilities [39] ). General intelligence was assessed using an age appropriate version of the Wechsler scales [33] [34] [35] [36] . Attentional processes were measured using the Conners' Continuous Performance Test in which participants are asked to respond when presented with any letter except "X" [40] . We used a principal components analysis with a varimax rotation to reduce the CPT data dimensions -see Supplement A4, Table B4 . The first emergent first factor is held to represent focused attention, the second reflects perseverative/impulsive responding and the final factor reflects sustained attention [41] . Missing cognitive data were imputed (missingness ranged from 3% for processing speed to 14% for working memory) using an iterative robust model-based imputation approach (R Statistical Software IRMI); [42] . Participants taking psychostimulants were asked to stop the medication at least 24 h before testing. These cognitive analyses included 490 participants.
PRS calculation
Genotyping was conducted on extracted DNA (details in Supplement A5) using the Illumina HumanOmniEx-pressExome-8v1-2 array with genome build GRCh37/ hg19. Calls were made using GenomeStudio version 2.0.3 and exported to PLINK format using GenomeStudio's PLINK Input Report Plug-in v2.1.4. SNPs were filtered to include only those (1) present in the PGC GWAS (2) with < 10% missing genotypes (3) minor allele frequency > = 0.01, genotyped in more than 99% of participants, (4) and at Hardy-Weinberg equilibrium of 10 −5 . In total, 544,897 SNPs were retained for PRS analysis.
The PRS were calculated as the sum of disorder-associated alleles across the genome, weighted by effect sizes from relevant study group within the Psychiatric Genetics Consortium: for ADHD [43] ; for ASD [44] ; for schizophrenia [45] . PRSice was used [46] , with base SNP clumping to remove linkage disequilibrium (LD threshold = 0.1, distance threshold = 250 Kb). Imputation was performed using data from the 1000 Genomes Project, which includes genetic data from 26 subpopulations (The 1000 Genomes Project Consortium, 2015) . We included a range of PRS at increasingly liberal significance thresholds (p < 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5) as a significant part of heritability comes from a large number of common SNPs, each of which individually has too small of an effect to be detected at the stringent genome-wide significance level, even with current sample sizes [46, 47] . The Psychiatric Genomics Consortium data set that was used as the basis for the PRS did not contain the recently genotyped cohort. Data from this study are being deposited in dbGAP for those individuals who consented.
Statistical analyses
Mixed model regression tested for associations between PRS and symptoms. Inattention and hyperactivity-impulsivity were considered separately in view of their partly distinct genetic etiologies, cognitive substrates, comorbidities, and dissociable developmental trajectories [48] [49] [50] [51] [52] . Mixed model regression (implemented in R package lme4 [53] ) was used as it allows the inclusion of a random term for family identity to account for nuclear or extended familial relatedness. Age and sex were entered as covariates in all analyses involving working memory and measures of attention.
Mediation analyses (using the R package Mediation [54] ) were used to parse the significant associations between PRS, the candidate cognitive and neuroanatomic mediators, and symptoms-detailed in Supplement A6. For the cognitive mediators, a bootstrapping approach with 10,000 resamples provided a bias corrected confidence interval for estimates. We tested the five levels of polygenic risk that were significantly associated with hyperactivity-impulsivity across six cognitive domains. To correct for this multiple testing, we applied a false discovery rate and indicate the results that survived this adjustment (at q < 0.05).
In the neural analyses, imaging data were first residualized to remove the effects of age, sex, motion, and quality control scores. Mediation analyses of the neuroanatomic and DTI data were conducted at the voxel level to identify clusters that significantly mediated (at p < 0.05, with 1000 bootstraps per voxel) the association between PRS and symptoms. To test significance, we ran 250 permutations of the data, holding constant participant and family identity, but shuffling without repetition the residualized voxel-wise data. For each permutation iteration we obtained a spatial map of voxel-wise mediation (and p values) under the null hypothesis. We then determined the largest cluster seen at a voxel-wise p < 0.05 under each iteration. After running all permutations, we established a null distribution of maximal cluster size. From this null distribution, we then determined the probability of seeing the observed cluster. These analyses returned five clusters (three in DTI and two in anatomy) that showed significant mediation consistently across PRS thresholds. A false discovery rate procedure was applied to control for multiple testing (of the levels of PRS across the five neural mediators), and we indicate the findings that survived this adjustment (at q < 0.05).
We also tested biologically plausible serial mediation pathways that included neural and cognitive variables (specifically, polygenic risk → brain regions → cognition → symptoms). These serial mediation analyses were conducted for all PRS thresholds that were significantly associated with symptoms. Such serial mediation analyses are not supported in the mixed model framework we used but are feasible for unrelated individuals, using the PROCESS Macro [55] , we thus used a cohort with only one member per family.
To check the robustness of findings, we repeated analyses (1) combining the two largest subpopulations; (2) entering psychostimulant medication as a covariate, and any psychotropic medication as a covariate; (3) excluding those who had comorbid disorders; (4) confining analyses to one member of each family, thus ensuring independence of observations.
Results

Polygenic risk and symptoms
Polygenic risk for ADHD across all PRS thresholds above p < 0.1, was significantly associated with symptoms of hyperactivity-impulsivity (at FDR q < 0.05), but not inattention- Table 1 . Neither polygenic risk for ASD nor schizophrenia was associated with ADHD symptoms. Similar results held for the combined White, non-Hispanic, and African American populations, with the exception of an association between the PRS for ASD and hyperactive-impulsive symptoms at thresholds p < 0.2-0.5- Supplemental Table B5 . Table 1 Neural mediators
Using mediation analyses we found that some facets of white matter microstructure mediated the link between polygenic risk for ADHD and hyperactivity-impulsivity- Table 2 , Fig. 1 . Specifically, axial diffusivity within regions of the right anterior and right superior corona radiata emerged as partial mediators across multiple PRS thresholds (at PRS < 0.1, for anterior corona radiata: indirect effect β = −0.031 (CI: −0.061 to −0.0078), p value for cluster by permutation < 0.004, accounting for 29% of the genetic effect; for superior corona radiata: indirect effect β = −0.022 (CI: −0.049 to −0.0033), p = 0.02; 21% of the genetic effect). Cortical dimensions also emerged as mediators- Table 2 . For thickness, a region within the left dorsomedial prefrontal cortex emerged as a partial mediator (at multiple thresholds; for PRS < 0.1 indirect effect β = −0.026 (CI: −0.057 to −0.0039), p value for cluster by permutation = 0.04; 24% of the genetic effect). For surface area, a region within the right lateral temporal cortex fully mediated the association between polygenic risk for ADHD and hyperactivity-impulsivity (at multiple thresholds; for PRS < 0.1 indirect effect β = 0.023 (CI: 0.002-0.052), p = 0.04; 22% of the genetic effect).
Cognitive mediators
Three of the six cognitive variables emerged as significant mediators across multiple PRS thresholds- Table 3 . Mediation was seen for working memory across PRS thresholds (for example, at PRS < 0.1, indirect effect β = 0.027 (CI: 0.0051-0.053), p = 0.01, FDR adjusted p = 0.05; 28% of the genetic effect), intelligent quotient (IQ) (indirect effect β = 0.019, (CI: 0.0036-0.042), p = 0.009, FDR adjusted p = 0.05; 20% of the genetic effect), and focused attention (indirect effect β = 0.016 (CI: 0.0021-0.037), p = 0.02, FDR adjusted p = 0.05; 17% of the genetic effect). In all cases, polygenic risk was no longer significantly associated with hyperactivity-impulsivity after each cognitive mediator was considered, implying each cognitive variable fully mediates the association between polygenic risk and symptoms. By contrast, processing speed, sustained attention and perseverative/impulsive responding did not emerge as significant mediators- Supplemental Table B7 . Table 3 Table 2 Serial mediation
We tested for serial mediation, (asking if polygenic risk → brain regions →cognition → symptoms). Two pathways emerged- Fig. 2 . The first linked polygenic risk and symptoms through axial diffusivity of anterior corona radiata and then to working memory (at multiple thresholds; for PRS < 0.1, indirect effect β = −0.01 (CI: −0.032 to −0.0009); 17% of the genetic effect) and also through focused attention (β = −0.0082 (CI: −0.027 to −0.0005); 14% of the genetic effect) -full results in Supplemental Table B8 . A similar serial pathway was found acting though axial diffusivity in more superior regions of the corona radiata, linking to working memory and focused attention. Serial mediation through the thickness of the left dorsomedial prefrontal cortex was only found only with working memory (at multiple thresholds; PRS < 0.1 β = −0.0086 (CI: −0.028 to −0.001); 37% of the genetic effect) - Supplemental Table B9 . There was no significant serial mediation from area of the lateral temporal cortex to cognition.
Robustness analyses
The pattern of results for cognitive and neural mediation mostly held when we combined the two largest subpopulations (white, non-Hispanic, and African American participants) with the exception of mediation by cortical thickness) (see Supplemental Tables B10-B12 ). Results for cognitive and neural mediators also held when we entered psychostimulant medication as a covariate, and when we entered any psychotropic medication as a covariate. In analyses that excluded those with current comorbid disorders, mediation by cognitive factors, cortical thickness, and white matter microstructure of the right superior corona radiata held; mediation by surface area did not. Finally, we repeated analyses retaining only the youngest member of each family, thus ensuring independence of observations. Again, the overall pattern of findings held for neural and cognitive variables with the exception of focused attention.
Discussion
Using a deeply phenotyped clinical cohort, we parse the neural and cognitive mechanisms that may explain the associations between polygenic risk for ADHD and its core symptoms. First, we identify mediating neural features: specifically, microstructural properties of white matter in the anterior corona radiata and the dimensions of the dorsomedial prefrontal and lateral temporal cortex. Second, we find mediation through some cognitive skills, including working memory, IQ, and focused attention. Finally, using serial mediation, we map a possible causal chain, whereby Table 3 Working The five levels of ADHD polygenic risk that were associated with hyperactivity-impulsivity were tested across six cognitive domains. Results for associations with impulsivity can be seen in Supplemental Table B6 . Results for processing speed, sustained attention, and perseverative/impulsive responding as mediators are given in Supplemental Table B7 . The percent of the total effect accounted for by the mediation model is given where there was significant cognitive mediation (* = nominal p < 0.05, ** = FDR corrected, q < .05) polygenic risk impacts on white matter microstructure, which in turn is linked to cognitive features that associate with hyperactivity-impulsivity. The findings showed diagnostic specificity: neither polygenic risk for ASD nor not schizophrenia was robustly associated with ADHD symptoms in the largest, white, non-Hispanic subpopulation. The main findings held for PRS defined across a range of thresholds and were robust to analyses which considered population structure and medication effects.
PRS and symptoms
We find that PRS for ADHD, defined using GWAS data from independent cohorts, was associated with symptoms of hyperactivity-impulsivity but not inattention. Although hyperactivity-impulsivity and inattention have similar heritability estimates, their genetic correlation is~0.6, indicating distinct as well as overlapping genetic contributors [56] . The two symptom domains differ in their forms of heritability: hyperactive-impulsive symptoms show more additive genetic influences (at 71%) than inattention (at 56%) [57] . Given that additive genetic influences are captured by common variant (SNP) heritability, this might explain why PRS for the diagnosis of ADHD was associated with hyperactivity-impulsivity rather than inattention in our cohort.
Neural mediators
We found that altered microstructure of white matter tracts, specifically axial diffusivity of the right anterior corona radiata, mediated the link between polygenic risk and symptoms. White matter tracts of this region connect the thalamus, anterior cingulate, and lateral prefrontal cortex, comprising a network that supports a host of cognitive function including cognitive control and working memory. Thus, it is perhaps unsurprising that individual differences in white matter microstructure of the anterior corona radiata have been associated with working memory capacity [58, 59] and aspects of cognitive control, such as resolving conflict between competing stimuli [60] . In addition, metaanalyses have implicated anomalous white matter microstructure of this region in ADHD [6] . Here, we extend the literature by reporting that microstructural properties of white matter in the right corona radiata are part of the causal chain that may link polygenic risk with symptoms. The dimensions of both the dorsomedial prefrontal cortex and right lateral temporal cortex also mediated the association between polygenic risk and symptoms. The dorsomedial prefrontal cortex has a role in multiple cognitive functions implicated in ADHD, including cognitive control, decision making, social cognition, and spatial working memory [61] [62] [63] [64] . In this regard, it is noteworthy that there was serial mediation from the dimensions of the dorsomedial cortex through working memory to symptoms. The dorsomedial prefrontal and lateral temporal cortex are also functionally interconnected components of the default mode network, and are both robustly activated by making self-relevant, affective decisions [65] . It has been hypothesized that intrusions of the DMN into task-oriented processing results in some of the cognitive deficits seen in Supplemental Tables B8 and B9 ADHD, including deficient sustained attention and distractibility [66] [67] [68] . Our current finding that common variant risk may act through the structural substrate of the DMN to produce symptoms is also consistent with recent family studies that find the DMN to be both a heritable and disorder-associated brain network [8] .
Cognitive mediators
We replicate a recent report that working memory mediates the association between PRS for ADHD and symptoms [22] . This study also found mediation by measures of arousal which unfortunately we did not include. Why do some cognitive skills such as working memory mediate the relationship between polygenic risk for ADHD and symptoms of hyperactivity-impulsivity, whereas others such as processing speed do not? In the general population, memory and intelligence show substantial genetic correlation with one another but not with processing speed [69] . Working memory and IQ are also genetically correlated with ADHD, whereas a genetic overlap between ADHD and processing and attentional measures has not yet been established [70, 71] . Thus, our results are consistent with the presence of genetic correlations between ADHD and some cognitive skills (e.g., working memory and general intelligence) but not others (e.g., processing speed).
We also find that cognitive mediation was specific to symptoms of hyperactivity-impulsivity, not inattention. This is consistent with the concept of distinct genetic and cognitive pathways to each symptom domain. For example, twin studies find that the genetic overlap between reaction time variability and inattentive symptoms is largely distinct from the genetic overlap seen between measures of impulsive responding and symptoms of hyperactivity-impulsivity [49, 72, 73] . We similarly find pathways from polygenic risk to symptoms differ by domain: the cognitive skills that mediated the association between polygenic risk and hyperactivity-impulsivity did not act as mediators for inattention.
Limitations
Several limitations are noted. First, some participants were on psychotropic medications, mostly psychostimulants. Although we controlled for the acute psychostimulant effects by stopping the medication at least 24 h before testing, chronic effects are still possible. We note however, that the main results held when we excluded those on psychotropics. Some participants were related, but we controlled for the non-independence of their observations using a random term in mixed model regression analyses. We also considered the role of comorbidities and found that the pattern of results generally held when those with current comorbidities were excluded. In addition, the results held when we included only one member from each family. The serial mediation analyses were conducted only with unrelated individuals, and more robust estimates would be obtained if there were accepted mediation methods for familial data. The effect sizes for the serial mediation were modest and extension to larger cohorts is a priority. The findings on the largest subpopulation generally held when the second largest subpopulation (of African Americans) was added. Interestingly, an association with PRS for ASD and hyperactivity-impulsivity became stronger in analyses that included both subpopulations. The GWAS data from the PGC included a wide age range, and similar estimates for ADHD polygenic risk emerged from predominately childhood and adult cohorts. Nonetheless, it remains possible that the contribution of common variant risk to childhood ADHD (which includes both those who will remit and those who will persist as adults) might differ in part from its contribution to adult ADHD (which includes only those with symptom persisting from childhood. Finally, although we tested many cognitive facets pertinent to ADHD, domains such as socio-emotional processing and response inhibition, which are also implicated in the disorder, were not included.
In conclusion, by leveraging multilevel data collected on a clinical cohort, we delineate pathways from polygenic risk for ADHD to hyperactive-impulsive symptoms through white matter microstructure, cortical anatomy, and cognition.
